A complement to kidney disease: CFHR5 nephropathy.
Karumanchi
S Ananth
SA
Howard Hughes Medical Institute, Beth Israel Deaconess Medical Center and Harvard Medical School, Boston, MA 02114, USA.
Thadhani
Ravi
R
D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D001706:Biopsy; D002878:Chromosomes, Human, Pair 1; D003182:Complement C5 / Q000235:genetics*; D017242:Complement Factor H / Q000235:genetics*; D003937:Diagnosis, Differential; D018450:Disease Progression; D008040:Genetic Linkage; D005921:Glomerulonephritis / Q000097:blood / Q000150:complications / Q000175:diagnosis / Q000235:genetics* / Q000473:pathology*; D005922:Glomerulonephritis, IGA / Q000235:genetics / Q000473:pathology; D006417:Hematuria / Q000209:etiology*; D006801:Humans; D009154:Mutation; D012141:Respiratory Tract Infections / Q000150:complications
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D003182:Complement C5; D017242:Complement Factor H; C481642:eculizumab